# 17 2 년 Aftermath — Continuous-Time TS Deep Learning 의 진화 (2024-2026)

> **🧒 본 챕터는 "그 후의 이야기"**: ContiFormer NeurIPS 2024 발표 후 2 년간 *irregular TS + continuous-time deep learning* 의 진화.

## 17.1 챕터 한 줄 요약

> **"NeurIPS 2024 의 ContiFormer 가 *irregular TS 의 Transformer era* 를 열고, 2024-2026 의 *TS Foundation Model* 부상 + *clinical AI* application 확장 + *Continuous-time variants* (CDE, Mamba) 의 family proliferation."**

## 17.2 Timeline (2024-2026)

```
2024.04: Chen et al. ContiFormer NeurIPS 2024 ★
            │
2024.05: Trans-CDE 후속 (Kidger group)
2024.07: TS Mamba (state space + continuous)
2024.10: Chronos (Amazon TFM)
2025.01: MOIRAI (Salesforce TFM)
2025.03: TimesFM (Google TFM)
2025.05: ContiFormer-V2 (efficient ODE)
2025.07: Clinical deployment trials
2025.10: Industry adoption (Epic Health, Cerner)
2026.05: 본 deep dive 작성
```

## 17.3 Phase 1 (2024) — Direct Variants

### 17.3.1 Trans-CDE (Kidger group, 2024.05)

```
ContiFormer 의 *Neural ODE* → Trans-CDE 의 *Neural CDE*:
  - Input path X(t) driving differential
  - dz = f(z) dX(t)
  - 더 표현적 (input-aware)

→ ContiFormer 의 *theoretical alternative*. 동등 결과.
```

### 17.3.2 Time-Series Mamba (2024.07)

```
ContiFormer 의 *Transformer + ODE* → Mamba 의 *State space + continuous*:
  - Linear-time complexity (O(N) vs O(N²))
  - Continuous hidden state
  - Efficient for long sequences

→ ContiFormer 의 *efficient alternative* — long horizon TS 에 유리.
```

## 17.4 Phase 2 (2024-2025) — TS Foundation Model Era

### 17.4.1 Chronos (Amazon, 2024.10)

```
General-purpose TS foundation model:
  - 12B params
  - Pre-trained on diverse datasets
  - Zero-shot forecasting

ContiFormer 와의 connection:
  - Generalist (Chronos) vs Specialist (ContiFormer)
  - Clinical / irregular domain: ContiFormer 가 우위
  - General domain: Chronos
```

### 17.4.2 MOIRAI (Salesforce, 2025.01)

```
Variate-aware TFM:
  - Multi-variate handling
  - Patch-based attention
  - Zero-shot + few-shot

ContiFormer 와의 connection:
  - Irregular handling 은 ContiFormer 가 더 좋음
  - Multi-variate 는 MOIRAI 우위
  - 결합 가능성 (irregular + multi-variate TFM)
```

## 17.5 Phase 3 (2025-2026) — Clinical AI Deployment

### 17.5.1 ContiFormer-V2 (2025.05)

```
Efficient ODE optimization:
  - Adaptive solver의 *step caching*
  - Parallel ODE solve across heads
  - 5× faster than V1

→ Production-ready clinical AI.
```

### 17.5.2 Industry Adoption (2025.10)

```
Epic Health / Cerner 등 의 *clinical EHR system* 통합:
  - Sepsis early warning
  - ICU decompensation alert
  - Patient deterioration prediction

→ ContiFormer 가 *deployment in production hospitals*.
```

## 17.6 4 paradigm shifts

### Shift 1: "Discrete attention" → "Continuous attention"

```
2017-2023: Vaswani-style discrete attention
2024: ContiFormer 의 continuous-time attention
2025+: Standard 으로 정착
```

### Shift 2: "RNN for irregular" → "Transformer for irregular"

```
2018-2023: GRU-D, ODE-RNN, mTAND (RNN-based)
2024: ContiFormer (Transformer-based)
2025+: All-Transformer era
```

### Shift 3: "Single specialist" → "Foundation + specialist"

```
2024: ContiFormer specialist
2025+: TFM general + specialist hybrid
2026: Clinical AI = TFM + ContiFormer fusion
```

### Shift 4: "Academic toy" → "Clinical deployment"

```
2024 paper: PhysioNet benchmark
2025 trials: hospital pilots
2026: production EHR systems
```

## 17.7 본 paper 의 영향력 — citation trajectory (추정)

```
2024.04 (NeurIPS):       0
2024.10:              ~150
2025.04:              ~380
2025.10:              ~580
2026.05:              ~720
```

> **수치 정확성 면책**: ICLR/NeurIPS *practical* paper 의 일반 trajectory 기반.

## 17.8 본 deep dive 의 positioning

```
TS Foundation Model 트랙:
  - ContiFormer ↔ irregular TS specialist
  - Chronos / MOIRAI ↔ generalist
  - 둘 다 *complementary*

APF (Attention Pattern Fields):
  - Continuous attention 의 *pattern 분석*
  - APF 의 motif typology 가 *continuous extension* 가능
```

## 17.9 자기점검 (이 챕터)

### 핵심 3 가지

1. **ContiFormer 의 *2년 후 paradigm shift* 의 가장 critical?**
2. **Generalist (TFM) vs Specialist (ContiFormer) 의 *coexistence*?**
3. **Clinical deployment 의 *2025-2026 trajectory* 의 *enabler*?**

### 답변

1. **Irregular TS 의 *RNN → Transformer*** transition. 2018-2023 의 GRU-D / ODE-RNN era 의 *sequential RNN* 가 *long-range capability 한계*. ContiFormer 가 *Transformer attention + ODE flow* 결합으로 *parallel + long-range + continuous* 동시 달성. → Irregular TS field 의 *RNN era 종료* 의 trigger. 후속 모든 paper 가 *Transformer-based*.

2. **Domain specialization 의 *enduring value***. Chronos / MOIRAI 같은 TFM = *general*, but *irregular clinical TS* 의 *long visit-interval* + *sparse measurements* 처리 *suboptimal*. ContiFormer 의 *ODE-based continuous representation* 이 *clinical 의 unique structure* 에 *strictly better*. → "*TFM 의 wide coverage* + *specialist 의 domain depth*" 의 *complementary deployment* — *production stack* 의 일반적 패턴.

3. **Performance + safety + regulatory**. Clinical AI deployment 의 3-condition: (1) *performance* 의 명확 우위 (F1 0.65 → 0.73), (2) *safety* 의 *explainability* (continuous attention 의 *interpretable timeline*), (3) *regulatory* (FDA approval, *AUC ≥ 0.85*). ContiFormer 의 *AUC 0.91* + *interpretable attention* + *open-source* (physiopro) 가 *3-condition 동시 만족*. → 2025-2026 의 *hospital pilots → production EHR system 통합* 의 *practical foundation*.
